THC Cross-Tolerance to Anandamide-Like Compounds Varied Across Four Mouse Tests

Prior THC dosing did not reduce every response to anandamide-like compounds in mice. Cross-tolerance appeared for some compounds and behavioral measures, while hypothermic responses showed no cross-tolerance in the experiment.

Four endpoints provided different answers

Researchers examined spontaneous activity, a tail-flick pain response, rectal temperature and ring immobility associated with catalepsy. Repeated THC produced pronounced tolerance to THC's own effects across these measures. The comparison compounds were anandamide, 2-methylanandamide and O-1812.

The pattern depended on the compound

All three anandamide-like compounds showed cross-tolerance on the antinociceptive measure. Suppression of spontaneous activity showed cross-tolerance for 2-methylanandamide and O-1812, while catalepsy showed it for O-1812. None showed cross-tolerance for hypothermia. Where cross-tolerance appeared, its magnitude was smaller than the tolerance to THC described in the abstract.

Shared receptor pharmacology was not the whole answer

The authors suggested only partial overlap between anandamide-like compounds and traditional cannabinoids. They proposed regional receptor adaptation and endocannabinoid release as possible contributors, rather than demonstrating a single settled mechanism. These are experimental compounds and injected exposures, not interchangeable forms of consumer cannabis.

The study illustrates how the question 'Is there cross-tolerance?' can be incomplete. A useful answer identifies the prior exposure, challenge compound and measured function. Preserved temperature effects alongside reduced pain-response effects also prevent a global claim that prior THC made the animals insensitive to cannabinoids.

Related: interpreting cannabis tolerance claims.

Research cited

Wiley JL; Smith FL; Razdan RK; Dewey WL. Task specificity of cross-tolerance between Delta9-tetrahydrocannabinol and anandamide analogs in mice. European journal of pharmacology (2005). doi:10.1016/j.ejphar.2005.01.006. Findings discussed from the study abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

THC and CB1 Blockade Changed Fat Intake Differently Across Feeding Schedules in Female Rats

A female-rat feeding study found that THC increased fat intake in one access schedule while rimonabant reduced intake in another. The feeding history and experimental group mattered to the direction and persistence of the response. Limited access created different eating patterns Rats had unrestricted chow and water, with groups differing…

Spread the love

Read Article: THC and CB1 Blockade Changed Fat Intake Differently Across Feeding Schedules in Female Rats

mTOR Inhibition Prevented Some THC Memory Effects When Given Before Exposure, Not After Cessation

In a mouse THC study, mTOR inhibition prevented selected memory-related effects when given before exposure but did not prevent a residual cognitive deficit when introduced after chronic THC stopped. Timing changed the intervention's result. Acute effects separated by endpoint Temsirolimus prevented acute anxiety-like and amnesic-like effects. THC-related anxiolysis, hypothermia, reduced…

Spread the love

Read Article: mTOR Inhibition Prevented Some THC Memory Effects When Given Before Exposure, Not After Cessation

Partial MAGL Inhibition Preserved Repeated Pain-Response and Gastric Benefits in Mice

A mouse study found that repeated lower-dose JZL184 preserved antinociceptive and gastroprotective effects that became tolerant under higher-dose regimens. The result supports a dose-dependent experimental window, not a validated human treatment schedule. Two disease-related models were used Researchers examined neuropathic pain after sciatic nerve constriction and gastric hemorrhage induced by…

Spread the love

Read Article: Partial MAGL Inhibition Preserved Repeated Pain-Response and Gastric Benefits in Mice

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us